S.03.05 Prioritizing augmentation strategies in resistant depression
β Scribed by Willem A. Nolen
- Book ID
- 118599654
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 288 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0924-977X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Approximately 3040% of elderly patients with major depression have inadequate response to an initial therapeutic trial of antidepressant medication. In these cases augmentation of the antidepressant has been recommended as one way of improving the rate of response. This article reviews the literatur
In depression that is resistant to tricyclic antidepressant (TCA) therapy, the substitution of a selective serotonin re-uptake inhibitor (SSRI), clomipramine, or a monoamine oxidase (MAO) inhibitor has been recommended. However, adding an additional antidepressant medication from a different drug cl
In the evaluation of treatment-resistant or treatment-refractory depression (TRD), true resistance to antidepressant therapy must be distinguished from inadequate dose, duration, or compliance with past antidepressant therapy. Reassessment of the diagnosis may reveal psychiatric comorbidity, the pr